PPARG and ASS1: Targets of Metabolic Alteration in Venetoclax / Decitabine Resistant Acute Myeloid Leukemia

被引：0
|
作者：
Yamatani, Kotoko [1 ]
Watanabe, Tatsuro [2 ]
Saito, Kaori [1 ]
Maiti, Abhishek [3 ]
Yamashita, Satoshi [4 ]
Khasawneh, Abdullah [1 ]
Paran, Faith Jessica [5 ]
Hayes, Kala [6 ]
Borthakur, Gautam [6 ]
Harman, Joe R. [7 ]
Kimura, Shinya [8 ]
DiNardo, Courtney D. [6 ]
Milne, Thomas A. [7 ]
Andreeff, Michael [9 ]
Tabe, Yoko [1 ,6 ]
Konopleva, Marina Y. [6 ,10 ,11 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan
[2] Saga Univ, Dept Drug Discovery & Biomed Sci, Fac Med, Saga, Japan
[3] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[4] Maebashi Inst Technol, Life Engn Dept, Fac Engn, Gunma, Japan
[5] Juntendo Univ, Grad Sch Med, Dept Res Support Utilizing Bioresource Bank, Tokyo, Japan
[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[7] Univ Oxford, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Mol Haematol Unit, Oxford, England
[8] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Saga, Japan
[9] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX USA
[10] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA
[11] Albert Einstein Coll Med, Bronx, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A Single-Center Comparison of Decitabine ± Venetoclax or FLAG in the Treatment of Secondary Acute Myeloid Leukemia
    Stonerock, Devon
    Homan, Morgan
    Marini, Bernard
    Perissinotti, Anthony
    Bixby, Dale
    Burke, Patrick
    Pettit, Kristen
    Benitez, Lydia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S210 - S210
  • [22] T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report
    Park, Sungwoo
    Jeong, Eun Jeong
    Kang, Jung Hun
    Lee, Gyeong-Won
    Go, Se-Il
    Lee, Dong-Hyun
    Koh, Eun-Ha
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (26) : 6200 - 6205
  • [23] ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms
    Mannelli, Francesco
    Guglielmelli, Paola
    Fazi, Paola
    Crea, Enrico
    Piciocchi, Alfonso
    Vignetti, Marco
    Amadori, Sergio
    Pane, Fabrizio
    Venditti, Adriano
    Vannucchi, Alessandro M.
    FUTURE ONCOLOGY, 2023, 19 (02) : 103 - 111
  • [24] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
  • [25] Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Pratz, Keith William
    Potluri, Jalaja
    Pullarkat, Vinod A.
    Jonas, Brian Andrew
    Wei, Andrew H.
    Becker, Pamela Sue
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel Aaron
    Letai, Anthony G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Venetoclax with decitabine or azacitidine in previously untreated TP53mut acute myeloid leukemia
    Zacholski, Kyle
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Thuy Ho
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    BLOOD, 2019, 133 (01) : 7 - 17
  • [28] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [29] Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells
    Valdez, Benigno C.
    Yuan, Bin
    Murray, David
    Nieto, Yago
    Popat, Uday
    Andersson, Borje S.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1634 - 1644
  • [30] Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
    Khalid Shoumariyeh
    Johannes Jung
    Michael Rassner
    Sandra Maria Dold
    Veronika Riebl
    Milena Pantic
    Georg Herget
    Reinhard Marks
    Michael Lübbert
    Ralph Wäsch
    Monika Engelhardt
    Annals of Hematology, 2021, 100 : 1637 - 1640
12345